The SARS-CoV-2 (2019-nCoV) Nucleocapsid Rabbit/Human Chimeric Monoclonal Antibody is a recombinant antibody engineered by combining the variable regions of a rabbit monoclonal antibody with human constant regions. It specifically targets the nucleocapsid (N) protein of SARS-CoV-2, a key structural protein involved in viral RNA binding and replication. This chimeric format enhances compatibility with human immune system components, making it particularly useful in therapeutic research, diagnostic assay development, and serological testing. The antibody is suitable for various applications, including ELISA, Western blotting, and immunohistochemistry, providing high sensitivity and specificity for SARS-CoV-2 detection.
GRMH03
GRMH03 reacts 2019-nCov Nucleocapsid Protein.
A recombinant 2019-nCov Nucleocapsid Protein expressed in E.coli.
Sandwich ELISA assay as a detection antibody, pair with rabbit monoclonal anti-2019-nCov NP clone GRM420
Validated in COVID-19 patient samples.
None
Research Use Only
Stable for 1 Year at -20.0°C from date of receipt
At Genebiosolution, our commitment lies in crafting cutting-edge solutions for researchers, clinicians, and diagnostic laboratories seeking excellence in immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH). With a focus on quality, reliability, and accuracy, our products empower advancements in molecular diagnostics and research methodologies.
